142 related articles for article (PubMed ID: 34712577)
1. Triheptanoin - Novel therapeutic approach for the ultra-rare disease mitochondrial malate dehydrogenase deficiency.
Laemmle A; Steck AL; Schaller A; Kurth S; Perret Hoigné E; Felser AD; Slavova N; Salvisberg C; Atencio M; Mochel F; Nuoffer JM; Gautschi M
Mol Genet Metab Rep; 2021 Dec; 29():100814. PubMed ID: 34712577
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell-derived hepatocytes reveal TCA cycle disruption and the potential basis for triheptanoin treatment for malate dehydrogenase 2 deficiency.
Mathis D; Koch J; Koller S; Sauter K; Flück C; Uldry AC; Forny P; Froese DS; Laemmle A
Mol Genet Metab Rep; 2024 Jun; 39():101066. PubMed ID: 38425868
[TBL] [Abstract][Full Text] [Related]
3. Malate dehydrogenase 2 deficiency is an emerging cause of pediatric epileptic encephalopathy with a recognizable biochemical signature.
Priestley JRC; Pace LM; Sen K; Aggarwal A; Alves CAPF; Campbell IM; Cuddapah SR; Engelhardt NM; Eskandar M; Jolín García PC; Gropman A; Helbig I; Hong X; Gowda VK; Lusk L; Trapane P; Srinivasan VM; Suwannarat P; Ganetzky RD
Mol Genet Metab Rep; 2022 Dec; 33():100931. PubMed ID: 36420423
[TBL] [Abstract][Full Text] [Related]
4. Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy.
Ait-El-Mkadem S; Dayem-Quere M; Gusic M; Chaussenot A; Bannwarth S; François B; Genin EC; Fragaki K; Volker-Touw CLM; Vasnier C; Serre V; van Gassen KLI; Lespinasse F; Richter S; Eisenhofer G; Rouzier C; Mochel F; De Saint-Martin A; Abi Warde MT; de Sain-van der Velde MGM; Jans JJM; Amiel J; Avsec Z; Mertes C; Haack TB; Strom T; Meitinger T; Bonnen PE; Taylor RW; Gagneur J; van Hasselt PM; Rötig A; Delahodde A; Prokisch H; Fuchs SA; Paquis-Flucklinger V
Am J Hum Genet; 2017 Jan; 100(1):151-159. PubMed ID: 27989324
[TBL] [Abstract][Full Text] [Related]
5. MDH1 deficiency is a metabolic disorder of the malate-aspartate shuttle associated with early onset severe encephalopathy.
Broeks MH; Shamseldin HE; Alhashem A; Hashem M; Abdulwahab F; Alshedi T; Alobaid I; Zwartkruis F; Westland D; Fuchs S; Verhoeven-Duif NM; Jans JJM; Alkuraya FS
Hum Genet; 2019 Dec; 138(11-12):1247-1257. PubMed ID: 31538237
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic RNA binding of the mitochondrial TCA cycle enzyme malate dehydrogenase.
Noble M; Chatterjee A; Sekaran T; Schwarzl T; Hentze MW
RNA; 2024 Jun; 30(7):839-853. PubMed ID: 38609156
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate carboxylase deficiency type C; variable presentation and beneficial effect of triheptanoin.
Bernhardt I; Van Dorp L; Dixon M; McSweeney M; Gan C; Baruteau J; Chakrapani A
JIMD Rep; 2024 Jan; 65(1):10-16. PubMed ID: 38186850
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
[TBL] [Abstract][Full Text] [Related]
9. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
[TBL] [Abstract][Full Text] [Related]
10. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.
Pascual JM; Liu P; Mao D; Kelly DI; Hernandez A; Sheng M; Good LB; Ma Q; Marin-Valencia I; Zhang X; Park JY; Hynan LS; Stavinoha P; Roe CR; Lu H
JAMA Neurol; 2014 Oct; 71(10):1255-65. PubMed ID: 25110966
[TBL] [Abstract][Full Text] [Related]
11. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-CoA from inflammation-induced fatty acids oxidation promotes hepatic malate-aspartate shuttle activity and glycolysis.
Wang T; Yao W; Li J; He Q; Shao Y; Huang F
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E496-E510. PubMed ID: 29763372
[TBL] [Abstract][Full Text] [Related]
13. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
[TBL] [Abstract][Full Text] [Related]
14. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
[TBL] [Abstract][Full Text] [Related]
15. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
[TBL] [Abstract][Full Text] [Related]
16. Probing the cardiac malate-aspartate shuttle non-invasively using hyperpolarized [1,2-
Chen AP; Lau AZ; Gu YP; Schroeder MA; Barry J; Cunningham CH
NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29106770
[TBL] [Abstract][Full Text] [Related]
17. Novel LRPPRC compound heterozygous mutation in a child with early-onset Leigh syndrome French-Canadian type: case report of an Italian patient.
Piro E; Serra G; Antona V; Giuffrè M; Giorgio E; Sirchia F; Schierz IAM; Brusco A; Corsello G
Ital J Pediatr; 2020 Sep; 46(1):140. PubMed ID: 32972427
[TBL] [Abstract][Full Text] [Related]
18. Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
Norris MK; Scott AI; Sullivan S; Chang IJ; Lam C; Sun A; Hahn S; Thies JM; Gunnarson M; McKean KN; Merritt JL
JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):230-238. PubMed ID: 33085788
[TBL] [Abstract][Full Text] [Related]
19. Complex I, V, and MDH2 deficient human skin fibroblasts reveal distinct metabolic signatures by
Meyer C; Hertig D; Arnold J; Urzi C; Kurth S; Mayr JA; Schaller A; Vermathen P; Nuoffer JM
J Inherit Metab Dis; 2024 Mar; 47(2):270-279. PubMed ID: 38084664
[TBL] [Abstract][Full Text] [Related]
20. Bi-allelic variants in MDH2: Expanding the clinical phenotype.
Ticci C; Nesti C; Rubegni A; Doccini S; Baldacci J; Dal Canto F; Ragni L; Cordelli DM; Donati MA; Santorelli FM
Clin Genet; 2022 Feb; 101(2):260-264. PubMed ID: 34766628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
